Sanjivani Paranteral Limited is engaged in the business of manufacturing pharmaceutical products. The Company’s products include oral solids, small volume parenteral and sterile powder formula. Its product category includes antibiotic, anti-emetic, non-steroidal anti-inflammatory drugs (NSAID) and analgesic, antimalarial, calcium and vitamin, sedative, steroid, cardiovascular, anti-fibrinolytic, anti-coagulant, vasoconstrictor, inotropic agent, multivitamin, nutrition, diuretic, anti-hypertensive, and others. Its anti-biotic includes Netilmicin Sulfate, Amikacin Sulfate, and Gentamycin Sulfate. Its anti-emetic includes Ranitidine Hydrochloride, Metoclopramide, Ondansetron, and Promethazine. Its NSAID and analgesic include Acetaminophen Injection and Diclofenac Sodium Injection. Its calcium and vitamins include Methylcobalamin 500 mcg/ml and Nicotinic Acid 10 mg/ml. Its sedative includes Midazolam Hydrochloride, and Diazepam. Its diuretic includes Furosemide.As of 25 May 2026, SANJIVANI PARANTERAL LTD. share price is ₹149.95. The stock opened at ₹146.35, compared to its previous close of ₹145.30. During today's trading session, SANJIVANI PARANTERAL LTD. share price moved in the range of ₹145.40 to ₹150.00, with an average price of ₹147.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹145.40 and a high of ₹150.00.
The market capitalization of SANJIVANI PARANTERAL LTD. is ₹178 Crs, with a P/E ratio of 26.7 and a dividend yield of 0.32%.